Evidence map›Paper›PMID 33801959›Full record

ArticleCells2021

Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients.

Giorgio A Croci, Valentina Vaira, Daria Trabattoni, Mara Biasin, Luca Valenti, Guido Baselli, Massimo Barberis, Elena Guerini Rocco, Giuliana Gregato, Mara Scandroglio and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Giorgio A CrociDepartment of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.ORCID 0000-0001-5979-7841
Valentina VairaDepartment of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.ORCID 0000-0003-4416-6216
Daria TrabattoniDepartment of Biomedical and Clinical Sciences L. Sacco, University of Milan, 20157 Milan, Italy.ORCID 0000-0001-9535-3359
Mara BiasinDepartment of Biomedical and Clinical Sciences L. Sacco, University of Milan, 20157 Milan, Italy.ORCID 0000-0003-3671-4235
Luca ValentiDepartment of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
Guido BaselliDepartment of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Massimo BarberisDepartment of Pathology, European Institute of Oncology, IRCCS, 20141 Milan, Italy.ORCID 0000-0002-0943-4804
Elena Guerini RoccoDepartment of Pathology, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Giuliana GregatoDivision of Clinical Haematology-Oncology, European Institute of Oncology, IRCCS, 20141 Milan, Italy.ORCID 0000-0003-0710-506X
Mara ScandroglioDepartment of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Evgeny FominskiyDepartment of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Alessandro PalleschiDepartment of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
Lorenzo RossoDepartment of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
Mario NosottiDepartment of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.ORCID 0000-0002-8571-121X
Mario ClericiDepartment of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
Stefano FerreroDivision of Pathology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
University of Milan · ITEuropean Institute of Oncology · ITVita-Salute San Raffaele University · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · IT

Funding

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Covid-19 Biobank" (RC100017A)Italian Minister of Health RF-2016-02364358
6 · The paper itself

Abstract

We herein characterize the immunopathological features of two Italian COVID-19 patients who underwent bilateral lung transplantation (bLTx). Removed lungs underwent histopathological evaluation. Gene expression profiling (GEP) for immune-related signatures was performed on lung specimens and SARS-CoV-2-stimulated peripheral blood mononuclear cells (PBMCs). Cytokine levels were measured on lungs, bronchoalveolar lavage fluids and in culture supernatants. Pathological assessment showed extensive lung damage with the pattern of proliferative to fibrotic phases, with diffuse alveolar damage mimicking usual interstitial pneumonia (UIP). Lungs' GEP revealed overexpression of pathogen recognition receptors, effector cytokines and chemokines, immune activation receptors and of the inflammasome components. Multiplex cytokine analysis confirmed a proinflammatory state, with high levels of monocyte/macrophage chemotactic and activating factors and of IL-6 and TNF-α. A similar profile was observed in SARS-CoV-2-stimulated PBMCs collected 7 days after transplant. The pattern of tissue damage observed in the lungs suggests that this may represent the output of protracted disease, resembling a diffuse UIP-like picture. The molecular immune profiling supports the paradigm of a persistent proinflammatory state and sustained humoral immunity, conditions that are maintained despite the iatrogenic immunosuppression.

Indexed as

Lung TransplantationAdolescentBronchoalveolar Lavage FluidChemokinesCOVID-19CytokinesGene Expression ProfilingGene Expression RegulationGenotypeHumansInflammasomesInterleukin-6Leukocytes, MononuclearLungLymph NodesMaleChemokinesCytokinesInflammasomesInterleukin-6Tumor Necrosis Factor-alphaARDSCOVID-19immunologylung transplantationSARS-CoV-2usual interstitial pneumonia

Identifiers

PMID33801959
PMCPMC7999589
OpenAlexW3135892040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.